Cartesian Therapeutics Inc
NASDAQ:RNAC
Income Statement
Earnings Waterfall
Cartesian Therapeutics Inc
Income Statement
Cartesian Therapeutics Inc
| Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
6
N/A
|
7
+18%
|
8
+11%
|
7
-7%
|
8
+11%
|
6
-24%
|
4
-32%
|
3
-25%
|
0
-93%
|
0
-66%
|
0
-37%
|
0
-61%
|
1
+5 212%
|
1
+1%
|
1
+1%
|
1
N/A
|
7
+621%
|
7
0%
|
7
0%
|
11
+70%
|
17
+47%
|
28
+67%
|
47
+71%
|
67
+42%
|
85
+27%
|
108
+27%
|
128
+18%
|
124
-3%
|
111
-11%
|
83
-25%
|
49
-41%
|
35
-29%
|
26
-25%
|
26
0%
|
54
+109%
|
48
-11%
|
39
-19%
|
35
-10%
|
2
-95%
|
2
+3%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(31)
|
(34)
|
(34)
|
(35)
|
(43)
|
(49)
|
(56)
|
(61)
|
(64)
|
(66)
|
(68)
|
(70)
|
(66)
|
(62)
|
(59)
|
(55)
|
(59)
|
(66)
|
(66)
|
(73)
|
(73)
|
(73)
|
(76)
|
(84)
|
(90)
|
(95)
|
(101)
|
(97)
|
(96)
|
(97)
|
(96)
|
(93)
|
(112)
|
(107)
|
(103)
|
(101)
|
(75)
|
(87)
|
(90)
|
(93)
|
|
| Selling, General & Administrative |
(8)
|
(9)
|
(9)
|
(9)
|
(13)
|
(15)
|
(17)
|
(19)
|
(19)
|
(20)
|
(19)
|
(19)
|
(18)
|
(18)
|
(18)
|
(17)
|
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(20)
|
(19)
|
(20)
|
(21)
|
(21)
|
(23)
|
(23)
|
(24)
|
(24)
|
(24)
|
(25)
|
(40)
|
(44)
|
(45)
|
(45)
|
(30)
|
(29)
|
(29)
|
(30)
|
|
| Research & Development |
(23)
|
(25)
|
(25)
|
(26)
|
(30)
|
(34)
|
(39)
|
(43)
|
(45)
|
(45)
|
(49)
|
(51)
|
(48)
|
(44)
|
(42)
|
(38)
|
(43)
|
(50)
|
(49)
|
(55)
|
(55)
|
(53)
|
(57)
|
(64)
|
(69)
|
(73)
|
(78)
|
(74)
|
(72)
|
(73)
|
(72)
|
(68)
|
(71)
|
(62)
|
(57)
|
(56)
|
(45)
|
(50)
|
(52)
|
(55)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
|
| Operating Income |
(25)
N/A
|
(26)
-4%
|
(27)
0%
|
(28)
-5%
|
(35)
-24%
|
(43)
-23%
|
(52)
-22%
|
(58)
-12%
|
(64)
-9%
|
(65)
-3%
|
(68)
-4%
|
(70)
-2%
|
(65)
+7%
|
(61)
+6%
|
(59)
+4%
|
(54)
+7%
|
(52)
+4%
|
(59)
-13%
|
(60)
0%
|
(61)
-3%
|
(57)
+8%
|
(46)
+20%
|
(29)
+37%
|
(17)
+42%
|
(5)
+72%
|
13
N/A
|
27
+101%
|
27
+1%
|
15
-46%
|
(15)
N/A
|
(47)
-222%
|
(59)
-24%
|
(86)
-46%
|
(81)
+5%
|
(49)
+40%
|
(53)
-9%
|
(36)
+32%
|
(52)
-44%
|
(88)
-68%
|
(91)
-4%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
0
|
2
|
2
|
(147)
|
(154)
|
(153)
|
(151)
|
0
|
8
|
9
|
8
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(10)
|
(6)
|
(10)
|
(26)
|
(14)
|
(18)
|
(2)
|
33
|
24
|
16
|
21
|
(1)
|
10
|
21
|
(5)
|
(39)
|
(46)
|
(60)
|
(34)
|
6
|
43
|
36
|
|
| Pre-Tax Income |
(25)
N/A
|
(27)
-7%
|
(27)
0%
|
(29)
-7%
|
(36)
-25%
|
(44)
-21%
|
(53)
-21%
|
(60)
-13%
|
(65)
-9%
|
(66)
-1%
|
(69)
-4%
|
(70)
-2%
|
(65)
+7%
|
(62)
+6%
|
(59)
+4%
|
(55)
+7%
|
(55)
0%
|
(63)
-14%
|
(71)
-12%
|
(68)
+3%
|
(69)
-1%
|
(74)
-7%
|
(45)
+39%
|
(38)
+17%
|
(10)
+74%
|
44
N/A
|
48
+9%
|
42
-13%
|
35
-16%
|
(16)
N/A
|
(36)
-128%
|
(36)
-2%
|
(239)
-555%
|
(274)
-15%
|
(249)
+9%
|
(264)
-6%
|
(77)
+71%
|
(38)
+51%
|
(36)
+5%
|
(48)
-33%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(16)
|
(16)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(25)
|
(27)
|
(27)
|
(29)
|
(36)
|
(44)
|
(53)
|
(60)
|
(65)
|
(66)
|
(69)
|
(70)
|
(65)
|
(62)
|
(59)
|
(55)
|
(55)
|
(63)
|
(71)
|
(68)
|
(69)
|
(74)
|
(45)
|
(53)
|
(26)
|
28
|
32
|
42
|
35
|
(15)
|
(35)
|
(36)
|
(220)
|
(255)
|
(230)
|
(245)
|
(77)
|
(38)
|
(36)
|
(48)
|
|
| Net Income (Common) |
(33)
N/A
|
(33)
-3%
|
(36)
-7%
|
(36)
0%
|
(41)
-14%
|
(46)
-13%
|
(53)
-15%
|
(60)
-13%
|
(65)
-9%
|
(66)
-1%
|
(69)
-4%
|
(70)
-2%
|
(65)
+7%
|
(62)
+6%
|
(59)
+4%
|
(55)
+7%
|
(55)
0%
|
(63)
-14%
|
(71)
-12%
|
(68)
+3%
|
(69)
-1%
|
(74)
-7%
|
(45)
+39%
|
(53)
-18%
|
(26)
+52%
|
28
N/A
|
32
+15%
|
42
+32%
|
35
-15%
|
(15)
N/A
|
(35)
-133%
|
(36)
-3%
|
(220)
-508%
|
(255)
-16%
|
(234)
+8%
|
(249)
-6%
|
(77)
+69%
|
(43)
+45%
|
(39)
+9%
|
(51)
-30%
|
|
| EPS (Diluted) |
-116.1
N/A
|
-118.32
-2%
|
-322.08
-172%
|
-59.46
+82%
|
-116.5
-96%
|
-74.8
+36%
|
-84.38
-13%
|
-81.33
+4%
|
-95.91
-18%
|
-88.69
+8%
|
-92.48
-4%
|
-94.01
-2%
|
-87.58
+7%
|
-48.02
+45%
|
-39.54
+18%
|
-35.62
+10%
|
-36.46
-2%
|
-19.92
+45%
|
-21.87
-10%
|
-19.45
+11%
|
-20.42
-5%
|
-20
+2%
|
-11.19
+44%
|
-13.9
-24%
|
-6.74
+52%
|
6.51
N/A
|
6.4
-2%
|
8.19
+28%
|
7.28
-11%
|
-2.94
N/A
|
-6.87
-134%
|
-7
-2%
|
-42.5
-507%
|
-47.07
-11%
|
-13.14
+72%
|
-11.59
+12%
|
-4.48
+61%
|
-1.64
+63%
|
-1.47
+10%
|
-1.94
-32%
|
|